Administrative considerations in an infective outbreak.
D001315:Australia; D003365:Costs and Cost Analysis; D003428:Cross Infection / Q000517:prevention & control*; D004196:Disease Outbreaks / Q000517:prevention & control*; D005672:Fusidic Acid / Q000627:therapeutic use; D006739:Hospital Administration; D006801:Humans; D008712:Methicillin / Q000494:pharmacology; D010347:Patient Care Planning / Q000191:economics; D010356:Patient Isolation / Q000191:economics; D010403:Penicillin Resistance; D010564:Personnel, Hospital; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control*; D013211:Staphylococcus aureus / Q000187:drug effects; D014640:Vancomycin / Q000627:therapeutic use
D005672:Fusidic Acid; D014640:Vancomycin; D008712:Methicillin